Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Neal S Young, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT01623167 · Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · active not recruiting · Severe Aplastic Anemia · principal investigator
- Ph1/Ph2NCT01441037 · Danazol for Genetic Bone Marrow and Lung DisordersNational Heart, Lung, and Blood Institute (NHLBI) · completed · Aplastic Anemia · principal investigator
- N/ANCT00968084 · Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) ProtocolsNational Heart, Lung, and Blood Institute (NHLBI) · completed · Inflammatory Disease, Autoimmune Disease, Immunologic Disease · principal investigator
- Ph2NCT00961064 · A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)National Heart, Lung, and Blood Institute (NHLBI) · completed · Myelodysplastic Syndromes, Thrombocytopenia · principal investigator
- Ph1NCT00533416 · Safety of ON 01910.Na in Patients With MyelodysplasiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Myelodysplastic Syndrome (MDS) · principal investigator
- N/ANCT00442195 · Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy VolunteersNational Heart, Lung, and Blood Institute (NHLBI) · recruiting · Healthy Volunteers · principal investigator
- N/ANCT00353639 · Telomere Repair Gene Mutation in Inflammatory Bowel DiseaseNational Heart, Lung, and Blood Institute (NHLBI) · completed · Inflammatory Bowel Disease · principal investigator
- Ph2NCT00195624 · Alemtuzumab to Treat Severe Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse · principal investigator
- N/ANCT00085670 · Cytokine Gene Polymorphisms in Bone Marrow FailureNational Heart, Lung, and Blood Institute (NHLBI) · completed · Bone Marrow Diseases · principal investigator
- Ph2NCT00061360 · Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Severe Aplastic Anemia · principal investigator
- N/ANCT00050115 · Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Hepatitis-Associated Aplastic Anemia · principal investigator
- Ph2NCT00001964 · Combination Therapy of Severe Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Severe Aplastic Anemia · principal investigator
- Ph2NCT00001626 · Comparing Therapies for the Treatment of Severe Aplastic AnemiaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Severe Aplastic Anemia (SAA) · principal investigator
- N/ANCT00001214 · Collection of Blood From Patients With PancytopeniaNational Heart, Lung, and Blood Institute (NHLBI) · completed · Pancytopenia · principal investigator
- N/ANCT00001627 · Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research PurposesNational Heart, Lung, and Blood Institute (NHLBI) · completed · Bone Marrow Diseases, Healthy Volunteers · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.